A systematic literature review was performed to assess the research trend on zoonotic orthopoxviruses (ZOPXV) asdiseaseagentsand asvectors for biomedicalduring 2000–2023.Ithas beenevidenced thatdespitethelimited number of research groups that have worked on ZOPXV diseases, they largely contributed not to turn off the spotlight. Given the small size of the ZOPXV research network, the epidemiological data remain restricted to a limited number of geographical contexts. Some inconsistencies between the geographic provenance of authors and the study area particularly in Africa were identified. MPX represents an exception, as the scientific interest has grown over the last 20 years, starting with the first outbreak outside endemic areas in 2003 and culminating during and after the 2022 pandemic, that boosted the number of publications from different countries over the last 2 years. Since the beginning of the millennium, authors have warned about the effects of waning immunity, aftercessationofsmallpoxvaccination,andidentifiedmanysocialandecologicalfactorsboostingtheemergence and spread of the diseases. ZOPXV diseases remain neglected by the global health agenda, leading to the adoption of reactive measures in the event of an emergency.
De Pascali, A.M., Brandolini, M., Peli, L., Sambri, V., Cricca, M., Scagliarini, A. (2024). Zoonotic orthopoxviruses after smallpox eradication: A shift from crisis response to a One Health approach. IJID ONE HEALTH, 2, 1-8 [10.1016/j.ijidoh.2024.100018].
Zoonotic orthopoxviruses after smallpox eradication: A shift from crisis response to a One Health approach
De Pascali A. M.Methodology
;Brandolini M.Writing – Original Draft Preparation
;Sambri V.Supervision
;Cricca M.Writing – Review & Editing
;Scagliarini A.
Conceptualization
2024
Abstract
A systematic literature review was performed to assess the research trend on zoonotic orthopoxviruses (ZOPXV) asdiseaseagentsand asvectors for biomedicalduring 2000–2023.Ithas beenevidenced thatdespitethelimited number of research groups that have worked on ZOPXV diseases, they largely contributed not to turn off the spotlight. Given the small size of the ZOPXV research network, the epidemiological data remain restricted to a limited number of geographical contexts. Some inconsistencies between the geographic provenance of authors and the study area particularly in Africa were identified. MPX represents an exception, as the scientific interest has grown over the last 20 years, starting with the first outbreak outside endemic areas in 2003 and culminating during and after the 2022 pandemic, that boosted the number of publications from different countries over the last 2 years. Since the beginning of the millennium, authors have warned about the effects of waning immunity, aftercessationofsmallpoxvaccination,andidentifiedmanysocialandecologicalfactorsboostingtheemergence and spread of the diseases. ZOPXV diseases remain neglected by the global health agenda, leading to the adoption of reactive measures in the event of an emergency.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
